References
- Campello C, Le Floch A, Parker F et al. Neuroepithelial intra medullary spinal cord tumors in adults: study of 70 cases. Presented at: 61st American Academy of Neurology Annual Meeting. Seattle, WA, USA 25 April–2 May 2009.
- Raco A, Esposito V, Lenzi J et al. Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery56(5), 972–981 (2005).
- Parsa AT, Lee J, Parney IF et al. Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. J. Neurooncol.69(1–3), 291–318 (2004).
- Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: current classification and MRI features. Neuroradiology50(4), 301–314 (2008).
- Helseth A, Mork SJ. Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J. Neurosurg.71(6), 842–845 (1989).
- Cooper PR, Epstein F. Radical resection of intramedullary spinal cord tumors in adults. Recent experience in 29 patients. J. Neurosurg.63(4), 492–499 (1985).
- McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J. Neurosurg.72(4), 523–532 (1990).
- Volpp PB, Han K, Kagan AR, Tome M. Outcomes in treatment for intradural spinal cord ependymomas. Int. J. Radiat. Oncol. Biol. Phys.69(4), 1199–1204 (2007).
- Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J. Neurooncol.47(3), 231–238 (2000).
- Linstadt DE, Wara WM, Leibel SA et al. Postoperative radiotherapy of primary spinal cord tumors. Int. J. Radiat. Oncol. Biol. Phys.16(6), 1397–1403 (1989).
- Gomez DR, Missett BT, Wara WM et al. High failure rate in spinal ependymomas with long-term follow-up. Neurooncology7(3), 254–259 (2005).
- Chamberlain MC. Etoposide for recurrent spinal cord ependymoma. Neurology58(8), 1310–1311 (2002).
- Begemann M, De Angelis LM. Chemotherapeutic treatment of ependymomas at Memorial Sloan–Kettering Cancer Center from 1994 to 2000. Proc. Am. Soc. Clin. Oncol.20, 65A–258A (2001).
- Guidetti B. Intramedullary tumours of the spinal cord. Acta Neurochirurgica17(1), 7–23 (1967).
- Rodrigues GB, Waldron JN, Wong CS, Laperriere NJ. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.48(3), 837–842 (2000).
- Minehan KJ, Brown PD, Scheithauer BW, Krauss WE, Wright MP. Prognosis and treatment of spinal cord astrocytoma. Int. J. Radiat. Oncol. Biol. Phys.73(3), 727–733 (2009).
- Kim MS, Chung CK, Choe G, Kim IH, Kim HJ. Intramedullary spinal cord astrocytoma in adults: postoperative outcome. J. Neurooncol.52(1), 85–94 (2001).
- Innocenzi G, Salvati M, Cervoni L, Delfini R, Cantore G. Prognostic factors in intramedullary astrocytomas. Clin. Neurol. Neurosurg.99(1), 1–5 (1997).
- Abdel-Wahab M, Etuk B, Palermo J et al. Spinal cord gliomas: a multi-institutional retrospective analysis. Int. J. Radiat. Oncol. Biol. Phys.64(4), 1060–1071 (2006).
- Chamberlain MC. Temozolomide for recurrent low-grade spinal cord gliomas in adults. Cancer113(5), 1019–1024 (2008).
- Kaley T, Mondesire-Crump I, Abrey L. Temozolomide for spinal cord high-grade glomas. Presented at: 61st American Academy of Neurology 2009 Annual Meeting. Seattle, WA, USA, 25 April–2 May 2009.
- Allen JC, Aviner S, Yates AJ et al. Treatment of high-grade spinal cord astrocytoma of childhood with “8-in-1” chemotherapy and radiotherapy: a pilot study of CCG-945. Children’s Cancer Group. J. Neurosurg.88(2), 215–220 (1998).
- Lefkowitz IB, Packer RJ, Sutton LN et al. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer61(5), 896–902 (1988).
- Lowis SP, Pizer BL, Coakham H, Nelson RJ, Bouffet E. Chemotherapy for spinal cord astrocytoma: can natural history be modified? Childs Nerv. Syst.14(7), 317–321 (1998).
- Packer RJ, Lange B, Ater J et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J. Clin. Oncol.11(5), 850–856 (1993).
- Lee DK, Choe WJ, Chung CK, Kim HJ. Spinal cord hemangioblastoma: surgical strategy and clinical outcome. J. Neurooncol.61(1), 27–34 (2003).
- Murota T, Symon L. Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery25(5), 699–707 (1989).
- Miller DJ, McCutcheon IE. Hemangioblastomas and other uncommon intramedullary tumors. J. Neurooncol.47(3), 253–270 (2000).
- Cerejo A, Vaz R, Feyo PB, Cruz C. Spinal cord hemangioblastoma with subarachnoid hemorrhage. Neurosurgery27(6), 991–993 (1990).
- Dijindjian M, Djindjian R, Houdart R, Hurth M. Subarachnoid hemorrhage due to intraspinal tumors. Surg. Neurol.9(4), 223–229 (1978).
- Kormos RL, Tucker WS, Bilbao JM, Gladstone RM, Bass AG. Subarachnoid hemorrhage due to a spinal cord hemangioblastoma: case report. Neurosurgery6(6), 657–660 (1980).
- Minami M, Hanakita J, Suwa H et al. Cervical hemangioblastoma with a past history of subarachnoid hemorrhage. Surg. Neurol.49(3), 278–281 (1998).
- Yu JS, Short MP, Schumacher J, Chapman PH, Harsh GR 4th. Intramedullary hemorrhage in spinal cord hemangioblastoma. Report of two cases. J. Neurosurg.81(6), 937–940 (1994).
- Eskridge JM, McAuliffe W, Harris B et al. Preoperative endovascular embolization of craniospinal hemangioblastomas. Am. J. Neuroradiol.17(3), 525–531 (1996).
- Standard SC, Ahuja A, Livingston K, Guterman LR, Hopkins LN. Endovascular embolization and surgical excision for the treatment of cerebellar and brain stem hemangioblastomas. Surg. Neurol.41(5), 405–410 (1994).
- Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery33(3), 502–505 (1993).
- Vazquez-Anon V, Botella C, Beltran A, Solera M, Piquer J. Preoperative embolization of solid cervicomedullary junction hemangioblastomas: report of two cases. Neuroradiology39(2), 86–89 (1997).
- Ryu SI, Kim DH, Chang SD. Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg. Focus15(5), E10 (2003).
- Schuch G, de Wit M, Holtje J et al. Case 2. Hemangioblastomas: diagnosis of von Hippel–Lindau disease and antiangiogenic treatment with SU5416. J. Clin. Oncol.23(15), 3624–3626 (2005).
- Benesch M, Windelberg M, Sauseng W et al. Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann. Oncol.19(4), 807–813 (2008).
- Jallo GI, Freed D, Epstein FJ. Spinal cord gangliogliomas: a review of 56 patients. J. Neurooncol.68(1), 71–77 (2004).
- Patel U, Pinto RS, Miller DC et al. MR of spinal cord ganglioglioma. AJNR Am. J. Neuroradiol.19(5), 879–887 (1998).
- Amini A, Chin SS, Schmidt MH. Malignant transformation of conus medullaris ganglioglioma: case report. J. Neurooncol.82(3), 313–315 (2007).
- Di Patre PL, Payer M, Brunea M et al. Malignant transformation of a spinal cord ganglioglioma – case report and review of the literature. Clin. Neuropathol.23(6), 298–303 (2004).
- Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery42(5), 1038–1043 (1998).
- Bekar A, Cordan T, Evrensel T, Tolunay S. A case of primary spinal intramedullary lymphoma. Surg. Neurol.55(5), 261–264 (2001).
- Heran NS, Yong RL, Heran MS, Yip S, Fairholm D. Primary intradural extraarachnoid hodgkin lymphoma of the cervical spine. Case report. J. Neurosurg. Spine5(1), 61–64 (2006).
- Itami J, Mori S, Arimizu N et al. Primary intramedullary spinal cord lymphoma: report of a case. Jpn. J. Clin. Oncol.16(4), 407–412 (1986).
- Machiya T, Yoshita M, Iwasa K, Yamada M. Primary spinal intramedullary lymphoma mimicking ependymoma. Neurology68(11), 872 (2007).
- Pels H, Vogt I, Klockgether T, Schlegel U. Primary non-Hodgkin’s lymphoma of the spinal cord. Spine25(17), 2262–2264 (2000).
- Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J. Clin. Oncol.18(17), 3144–3150 (2000).
- Aoyama T, Hida K, Ishii N et al. Intramedullary spinal cord germinoma – 2 case reports. Surg. Neurol.67(2), 177–183 (2007).
- Chute DJ, Burton EC, Klement IA, Frazee JG, Vinters HV. Primary intramedullary spinal cord germinoma: case report. J. Neurooncol.63(1), 69–73 (2003).
- Hata M, Ogino I, Sakata K et al. Intramedullary spinal cord germinoma: case report and review of the literature. Radiology223(2), 379–383 (2002).
- Itoh Y, Mineura K, Sasajima H, Kowada M. Intramedullary spinal cord germinoma: case report and review of the literature. Neurosurgery38(1), 187–190; discussion 190–181 (1996).
- Matsuyama Y, Nagasaka T, Mimatsu K et al. Intramedullary spinal cord germinoma. Spine20(21), 2338–2340 (1995).
- Yang KY, Li SH, Lin JW et al. Concurrent chemoradiotherapy for primary cervical spinal cord germinoma. J. Clin. Neurosci.16(1), 115–118 (2009).
- Connolly ES Jr, Winfree CJ, McCormick PC, Cruz M, Stein BM. Intramedullary spinal cord metastasis: report of three cases and review of the literature. Surg. Neurol.46(4), 329–337 (1996).
- Denaro L, Pallini R, Di Muro L et al. Primary hemorrhagic intramedullary melanoma. Case report with emphasis on the difficult preoperative diagnosis. J. Neurosurg. Sci.51(4), 181–183 (2007).
- Farrokh D, Fransen P, Faverly D. MR findings of a primary intramedullary malignant melanoma: case report and literature review. Am. J. Neuroradiol.22(10), 1864–1866 (2001).
- Francois P, Lioret E, Jan M. Primary spinal melanoma: case report. Br. J. Neurosurg.12(2), 179–182 (1998).
- Larson TC 3rd, Houser OW, Onofrio BM, Piepgras DG. Primary spinal melanoma. J. Neurosurg.66(1), 47–49 (1987).
- Salpietro FM, Alafaci C, Gervasio O et al. Primary cervical melanoma with brain metastases. Case report and review of the literature. J. Neurosurg.89(4), 659–666 (1998).
- Vaquero J, de Prado F, Pedrosa M. Primary intraparenchymatous spinal cord melanoma. Spinal Cord36(5), 363–365 (1998).
- Yamasaki T, Kikuchi H, Yamashita J, Asato R, Fujita M. Primary spinal intramedullary malignant melanoma: case report. Neurosurgery25(1), 117–121 (1989).
- Jinnai T, Koyama T. Clinical characteristics of spinal nerve sheath tumors: analysis of 149 cases. Neurosurgery56(3), 510–515 (2005).
- Conti P, Pansini G, Mouchaty H, Capuano C, Conti R. Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature. Surg. Neurol.61(1), 34–43 (2004).
- Dodd RL, Ryu MR, Kamnerdsupaphon P et al. CyberKnife radiosurgery for benign intradural extramedullary spinal tumors. Neurosurgery58(4), 674–685; discussion 674–685 (2006).
- Gerszten PC, Burton SA, Ozhasoglu C, McCue KJ, Quinn AE. Radiosurgery for benign intradural spinal tumors. Neurosurgery62(4), 887–895 (2008).
- Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J. Med. Genet.43(4), 289–294 (2006).
- Gezen F, Kahraman S, Canakci Z, Beduk A. Review of 36 cases of spinal cord meningioma. Spine25(6), 727–731 (2000).
- Peker S, Cerci A, Ozgen S et al. Spinal meningiomas: evaluation of 41 patients. J. Neurosurg. Sci.49(1), 7–11 (2005).
- Solero CL, Fornari M, Giombini S et al. Spinal meningiomas: review of 174 operated cases. Neurosurgery25(2), 153–160 (1989).
- Sacko O, Haegelen C, Mendes V et al. Spinal meningioma surgery in elderly patients with paraplegia or severe paraparesis: a multicenter study. Neurosurgery64(3), 503–509 (2009).
- Ryu SI, Chang SD, Kim DH et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery49(4), 838–846 (2001).
- Chamberlain MC, Blumenthal DT. Intracranial meningiomas: diagnosis and treatment. Expert Rev. Neurother.4(4), 641–648 (2004).
- Chamberlain MC, Glantz MJ. Interferon-α for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer113(8), 2146–2151 (2008).
- Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology69(10), 969–973 (2007).
- DeBoer R, Grimm SA, Chandler J et al. A Phase II trial of PTK-787 (PTK/ZK) in recurrent or progressive meningiomas. American Society of Clinical Oncology 2008 Annual Meeting, Chicago, IL. J. Clin. Oncol.26(Suppl.) (2008) (Abstract 2060).
- Kaley T Wen P, Karimi S et al. Phase II trial of sunitinib (SU011248) in patients with recurrent or inoperable meningioma. Presented at: Society for Neuro-Oncology 2008 Annual Meeting. Las Vegas, NV, USA 20–-23 November 2008.
- Kyritsis AP. Chemotherapy for meningiomas. J. Neurooncol.29(3), 269–272 (1996).
- Mason WP, Gentili F, Macdonald DR et al. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresecend point meningioma. J. Neurosurg.97(2), 341–346 (2002).